Sex Hormone-Binding Globulin Prevents Carbon Tetrachloride-Induced Liver Fibrosis Development
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27114893 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Anna Álvarez-Guaita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, 08035 Barcelona, Spain. Hauptthemen laut MEDLINE: Carbon Tetrachloride, Liver Cirrhosis, Sex Hormone-Binding Globulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, European Regional Development Funds.
Abstract (Originalsprache)
Circulating sex hormone-binding globulin (SHBG) concentrations are lower in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), reflecting its potential role in metabolic liver dysfunction. Our prior studies demonstrated that SHBG can attenuate MASLD by limiting hepatic lipid deposition, partly through suppression of lipogenic pathways, in both cellular and animal models. In the present work, we have examined whether SHBG could protect against development of liver fibrosis. For this purpose, in vitro and in vivo studies were performed. In vitro, we used co-cultures of human hepatocellular carcinoma cell line (HepG2) and human hepatic stellate cell line (LX-2) cells transfected using an SHBG expression vector vs. vehicle and treated with transforming growth factor beta 1 (TGF-β1). For in vivo studies we used wild-type and human SHBG transgenic mice developing liver fibrosis induced by carbon tetrachloride (CCl4). Our results clearly showed that SHBG overexpression reduced the TGF-β1-induced expression in collagen in LX-2 cells. Moreover, SHBG overexpression reduced the CCl4 induced liver fibrosis in both male and female mice. Histological examination revealed that SHBG transgenic mice had reduced NAS score and decreased collagen accumulation, assessed by Sirious Red staining. In addition, human SHBG transgenic mice treated with CCl4 exhibited lower collagen 1A1 (Col1A1) protein levels when compared with wild-type CCl4 treated mice. Mechanistically, SHBG attenuated fibrosis primarily through modulation of the TGF-β1/matrix metalloproteinases (MMPs)/tissue inhibitor metalloproteinases 1 (TIMP1) axis, characterized by reduced TGF-β1 levels, increased metalloprotease activity, and decreased TIMP1 levels compared with wild-type CCl4 treated mice. Notably, female SHBG transgenic mice exhibited greater protection against fibrosis than males, indicating a sex-dependent effect likely mediated by differences in sex steroid signaling. Taken together, we demonstrate for the first time that SHBG protects against liver fibrosis by promoting collagen degradation via the TGF-β1/MMPs/TIMP1 pathway. Further research is needed to elucidate the role of sex steroids in the regulation of MMPs and the observed sexual dimorphism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
- Autonomous University of Barcelona, 08193 Barcelona, Spain.
- Diabetes and Metabolism Research Unit and CIBERDEM, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.
- Human Pathology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
ORCID-Profile: Cristina Hernández, Rafael Simó
Förderung
- Instituto de Salud Carlos III
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
- European Regional Development Funds
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
Álvarez-Guaita, A., Briansó-Llort, L., Cabrera-Serra, J., Fuertes-Rioja, L., Ramos-Pérez, L., Salcedo-Allende, M. T., Hernández, C., Simó, R., & Selva, D. M. (2026). Sex Hormone-Binding Globulin Prevents Carbon Tetrachloride-Induced Liver Fibrosis Development. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27114893
Vancouver
Álvarez-Guaita A, Briansó-Llort L, Cabrera-Serra J, Fuertes-Rioja L, Ramos-Pérez L, Salcedo-Allende MT, et al. Sex Hormone-Binding Globulin Prevents Carbon Tetrachloride-Induced Liver Fibrosis Development. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27114893
BibTeX
@article{lvarezGuaita2026,
author = {Álvarez-Guaita, Anna and Briansó-Llort, Laura and Cabrera-Serra, Julia and Fuertes-Rioja, Lidia and Ramos-Pérez, Lorena and Salcedo-Allende, María Teresa and Hernández, Cristina and Simó, Rafael and Selva, David M},
title = {Sex Hormone-Binding Globulin Prevents Carbon Tetrachloride-Induced Liver Fibrosis Development},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27114893}
}
EUVIMED